Urokinase biosimilar (Sedico)

尿激酶生物类似药 (Sedico)

Report date: 2022/01/21 16:32:51

Base Information

Drug NameUrokinase biosimilar (Sedico)

Drug Alias Name尿激酶生物仿制药 (Sedico)Angikinase

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionUrokinase plasminogen activator stimulants

TargetsUrokinase plasminogen activator

Therapy Area/IndicationsThromboembolismMyocardial InfarctionPulmonary Embolism

Global Approved IndicationsThromboembolismMyocardial InfarctionPulmonary Embolism

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEgypt

Original Approved Date2014/01/01

Country/TerritoryEgypt

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesSedico

China Registration ClassN/A

Develop Information

Active CompaniesSedico

Inactive CompaniesN/A

Active IndicationsThromboembolismMyocardial InfarctionPulmonary Embolism

Inactive IndicationsN/A

Other Information

ATC CodeB01AD04